2024 ACMT-EAPCCT Transatlantic Toxicology Talks Series | Utilizing Fomepizole in Acetaminophen Poisoning
Recorded On: 02/05/2024
ACMT-EAPCCT Transatlantic Tox Talk
Utilizing Fomepizole in Acetaminophen Poisoning
90-m On-Demand Webinar
The inaugural event of the 2024 ACMT-EAPCCT Transatlantic Toxicology Talks series provides an engaging and intellectually enriching experience tailored specifically to medical practitioners. Recorded from a live virtual event held on February 5, 2024, this 90-minute on-demand webinar offers a unique opportunity to observe medical toxicology experts as they discuss the pivotal and time-sensitive topic of "Utilizing Fomepizole in Acetaminophen Poisoning."
Facilitated by the collaborative expertise of the European Association of Poison Control Centers (EAPCCT) and the American College of Medical Toxicology (ACMT), this asynchronous activity offers a comprehensive, multidimensional discourse that transcends continents. Viewers can anticipate a robust exchange of knowledge and an in-depth comprehension of Fomepizole's applications in poison management.
This inaugural session serves as the foundation for an educational series where medical experts unite to dissect intricate issues within the domain of medical toxicology.
Diane Calello, MD, FACMT
Professor of Emergency Medicine; Executive and Medical Director, New Jersey Poison Information and Education System; Chair, ACMT Education Committee
Rutgers New Jersey Medical School
Dr. Calello, a New Jersey native and devotee, is currently the Director of Medical Toxicology at Morristown Medical Center and a toxicologist at the New Jersey Poison Information and Education System (NJPIES). She has lectured and published on various facets of clinical toxicology, particularly as it pertains to extracorporeal treatment, intravenous lipid emulsion, and poisoning in the young child. Dr. Calello received her BA from the College of William and Mary and her MD from New Jersey Medical School. She completed residency training in pediatrics, and fellowship training in both pediatric emergency medicine and medical toxicology at the Children’s Hospital of Philadelphia and Poison Control Center in Philadelphia. Dr. Calello is board certified in pediatrics, pediatric emergency medicine, medical toxicology, and addiction medicine.
Kim Dalhoff, MD, DMSc, FEAPCCT
Professor of Clinical Pharmacology
Bispebjerg and Frederiksberg University Hospital
Dr. Kim Dalhoff received his MD from the University of Copenhagen in 1983. He is a specialist in hepatology and completed a clinical pharmacology degree in 2002.
James Dear, PhD
Chair of Clinical Pharmacology, Deanery of Clinical Sciences Centre for Cardiovascular Science
University of Edinburgh
Professor Dear trained in medicine at Oxford University and did a PhD in Pharmacology at University College London. Professor Dear spent 2 years at a research fellow at the National Institutes of Health, Bethesda, USA. Since 2005, Professor Dear has been a Clinical Pharmacologist/Toxicologist at the Edinburgh University. In 2012, Professor Dear was awarded an NHS Research Scotland (NRS) Career Research Fellowship. In 2020 Professor Dear was made Professor of Clinical Pharmacology.
Professor James Dear was the Chief Investigator on the Phase 1 POP Trial of calmangafodipir (published 2019) and will be the Chief Investigator on the phase 2/3 Albatross Trial. Funded by Egetis Therapeutics. Professor Dear Is Chief Investigator on the HiSNAP Trial of high dose NAC in acetaminophen overdose (funded by the Scottish Government) and the MAIL Trial of macrophage cell therapy in acetaminophen hepatotoxicity (funded by the UK Government).
Rob Hendrickson, MD
Professor of Emergency Medicine, Medical Director, Program Director
Oregon Health and Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology
Dr. Hendrickson graduated from the State University of New York, Downstate College of Medicine, and completed training in Emergency Medicine and Medical Toxicology at the Medical College of Pennsylvania. He is a Professor of Emergency Medicine at Oregon Health and Sciences University where he is Chief of the Section of Medical Toxicology, Program Director for the fellowship in medical toxicology, and the Medical Director of the Oregon Poison Center.
Christina Hantsch, MD, FACEP, FAACT, FACMT (Moderator)
Emergency Physician and Medical Toxicologist
Dr. Hantsch is a graduate of the Honors Program in Medical Education at Northwestern University. She completed an emergency medicine residency, including a year as chief resident, at the Medical College of Wisconsin and then continued her training in a medical toxicology fellowship at Vanderbilt University. After her fellowship, she spent nearly 22 years at Loyola University Chicago Stritch School of Medicine and Loyola University Medical Center. There, she established an inpatient toxicology clinical service and clinical rotations for graduate medical trainees and students in multiple fields. With an interest in medication management and safety, she joined the hospital Pharmacy and Therapeutics Committee, serving as member for 6 years before being appointed chair and leading the committee for another 6 years. Dr. Hantsch earned the academic rank of Professor of Emergency Medicine, was Director of the Division of Toxicology, and Director of Academic Affairs in the Department of Emergency Medicine. As a clinical faculty member, she was appointed to the Stritch Committee on Academic Rank and Tenure, serving for 7 years including 2 as a subcommittee chair leading revision of the clinician educator track guidelines. In 2018, she was the founding Program Director of the Loyola emergency medicine residency. Dr. Hantsch served for more than 8 years as Medical Director of the Illinois Poison Center. In addition, she is a regular organizer and contributor to many local, regional, and national/international continuing education programs. After leaving academics, she worked for the U.S. FDA in pharmacovigilance for a year. As of 2022, she is board certified in addiction medicine in addition to emergency medicine and medical toxicology. Dr. Hantsch was elected to the ACMT Board of Directors in 2021, is a member of the Education Committee, and chair of the Practice Committee.
Joshua D. King, MD, FACMT (Moderator)
Associate Professor, Medicine and Pharmacy; Medical Director, Maryland Poison Center
University of Maryland School of Medicine
Dr. King received his medical education from Penn State College of Medicine, and completed Internal Medicine residency and chief residency at the University of Virginia. He completed Nephrology fellowship at Johns Hopkins Hospital, and after returning to the University of Virginia as a nephrologist, completed a medical toxicology fellowship there. Dr. King is a clinician-educator nephrologist and medical toxicologist with clinical interests in extracorporeal treatment of poisonings, extracorporeal removal of therapeutic drugs, ICU nephrology, and medical education. As a clinician, he sees hospitalized patients at the University of Maryland Medical Center on our nephrology consultation service as well as our medical toxicology consult service. He is involved in education primarily at the graduate medical education level, and to a lesser extent undergraduate medical education. Dr. King is also the medical director of the Maryland Poison Center, which provides poisoning information and treatment recommendations benefitting thousands of Marylanders each year. Dr. King carries out medical oversight of recommendations for poisonings, envenomations, and overdoses to the public and health care providers; provides education to a variety of students (pharmacy and medical) and physicians (residents and fellows) who rotate with the center; he is involved in a variety of other activities aimed at treatment and prevention of poisoning. Dr. King's research interests are largely focused where nephrology and toxicology meet – extracorporeal removal of toxins (via dialysis, apheresis, and other modalities).